Atkin SL - Search Results

1

A case-control study of polychlorinated biphenyl association with metabolic and hormonal outcomes in polycystic ovary syndrome.

Brennan E, Kumar N, Drage DS, Cunningham TK, Sathyapalan T, Mueller JF, Atkin SL. Brennan E, et al. Among authors: atkin sl. J Environ Sci Health C Toxicol Carcinog. 2022;40(1):86-105. doi: 10.1080/26896583.2022.2043135. Epub 2022 Mar 14. J Environ Sci Health C Toxicol Carcinog. 2022. PMID: 35895927

2

Key developments in endocrinology.

Mistry D, Maung KH, Manuchehri AM, Sathyapalan T, Atkin S, England J. Mistry D, et al. Practitioner. 2005 Aug;249(1673):541, 543-7, 549 passim. Practitioner. 2005. PMID: 16108472 Review. No abstract available.

3

The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.

Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL. Cho LW, et al. Among authors: atkin sl. Ann Clin Biochem. 2006 May;43(Pt 3):217-9. doi: 10.1258/000456306776865188. Ann Clin Biochem. 2006. PMID: 16704758

4

Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging.

Sathyapalan T, Lowry M, Turnbull LW, Rowland-Hill C, Atkin SL. Sathyapalan T, et al. Among authors: atkin sl. Pituitary. 2007;10(3):233-6. doi: 10.1007/s11102-007-0044-8. Pituitary. 2007. PMID: 17541750

5

Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Manuchehri AM, Sathyapalan T, Lowry M, Turnbull LW, Rowland-Hill C, Atkin SL. Manuchehri AM, et al. Among authors: atkin sl. Pituitary. 2007;10(3):261-6. doi: 10.1007/s11102-007-0048-4. Pituitary. 2007. PMID: 17557207

6

Cardiometabolic aspects of polycystic ovarian syndrome.

Cho LW, Randeva HS, Atkin SL. Cho LW, et al. Among authors: atkin sl. Vasc Health Risk Manag. 2007;3(1):55-63. Vasc Health Risk Manag. 2007. PMID: 17583175 Free PMC article. Review.

7

Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.

Cho LW, Kilpatrick ES, Jayagopal V, Diver MJ, Atkin SL. Cho LW, et al. Among authors: atkin sl. Clin Endocrinol (Oxf). 2008 Mar;68(3):390-4. doi: 10.1111/j.1365-2265.2007.03053.x. Epub 2007 Sep 19. Clin Endocrinol (Oxf). 2008. PMID: 17888022

8

Cardiovascular risk in women with polycystic ovary syndrome.

Cho LW, Atkin SL. Cho LW, et al. Among authors: atkin sl. Minerva Endocrinol. 2007 Dec;32(4):263-73. Minerva Endocrinol. 2007. PMID: 18091663 Review.

9

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

Sathyapalan T, Cho LW, Kilpatrick ES, Coady AM, Atkin SL. Sathyapalan T, et al. Among authors: atkin sl. Clin Endocrinol (Oxf). 2008 Dec;69(6):931-5. doi: 10.1111/j.1365-2265.2008.03260.x. Epub 2008 Apr 10. Clin Endocrinol (Oxf). 2008. PMID: 18410553 Clinical Trial.

10

The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.

Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL. Sathyapalan T, et al. Among authors: atkin sl. J Clin Endocrinol Metab. 2009 Jan;94(1):103-8. doi: 10.1210/jc.2008-1750. Epub 2008 Oct 21. J Clin Endocrinol Metab. 2009. PMID: 18940877 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters